These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 1847606)

  • 41. [Morphometric analysis of fibrocystic breast disease].
    Guski H; Freitag A; Hufnagl P; Voss K; Wenzelides K; Simon H
    Zentralbl Allg Pathol; 1986; 132(4):293-300. PubMed ID: 3026118
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In situ and invasive lobular neoplasia of the breast.
    Hanby AM; Hughes TA
    Histopathology; 2008 Jan; 52(1):58-66. PubMed ID: 18171417
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The concept of minimal breast cancer and the pathologist's role in the diagnosis of "early carcinoma".
    Ackerman LV; Katzenstein AL
    Cancer; 1977 Jun; 39(6 Suppl):2755-63. PubMed ID: 194678
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Multicolor immunofluorescence reveals that p63- and/or K5-positive progenitor cells contribute to normal breast epithelium and usual ductal hyperplasia but not to low-grade intraepithelial neoplasia of the breast.
    Boecker W; Stenman G; Schroeder T; Schumacher U; Loening T; Stahnke L; Löhnert C; Siering RM; Kuper A; Samoilova V; Tiemann M; Korsching E; Buchwalow I
    Virchows Arch; 2017 May; 470(5):493-504. PubMed ID: 28303349
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cancer upgrades at excisional biopsy after diagnosis of atypical lobular hyperplasia or lobular carcinoma in situ at core-needle biopsy: some reasons why.
    Cohen MA
    Radiology; 2004 Jun; 231(3):617-21. PubMed ID: 15163803
    [No Abstract]   [Full Text] [Related]  

  • 46. "Borderline" breast lesions.
    Am J Surg Pathol; 1991 Nov; 15(11):1100-8. PubMed ID: 1656804
    [No Abstract]   [Full Text] [Related]  

  • 47. [Symptomology of non-invasive proliferative epithelial changes in the breast].
    Geppert M; Bachmann FF
    Med Welt; 1982 Jul; 33(28):1020-3. PubMed ID: 6289038
    [No Abstract]   [Full Text] [Related]  

  • 48. Precursor Lesions of the Low-Grade Breast Neoplasia Pathway.
    Collins LC
    Surg Pathol Clin; 2018 Mar; 11(1):177-197. PubMed ID: 29413656
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The diagnosis and management of pre-invasive breast disease: problems associated with management of pre-invasive lesions.
    Purushotham AD
    Breast Cancer Res; 2003; 5(6):309-12. PubMed ID: 14580248
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Immunohistochemical differentiation of atypical hyperplasia vs. carcinoma in situ of the breast.
    Masood S; Sim SJ; Lu L
    Cancer Detect Prev; 1992; 16(4):225-35. PubMed ID: 1281040
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pathology reporting in breast cancer screening. Royal College of Pathologists Working Group.
    J Clin Pathol; 1991 Sep; 44(9):710-25. PubMed ID: 1655830
    [No Abstract]   [Full Text] [Related]  

  • 52. Possible Prognostic Role of HER2/Neu in Ductal Carcinoma In Situ and Atypical Ductal Proliferative Lesions of the Breast.
    Daoud SA; Ismail WM; Abdelhamid MS; Nabil TM; Daoud SA
    Asian Pac J Cancer Prev; 2016; 17(8):3733-6. PubMed ID: 27644608
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Breast pathology: rationale for adopting the ductal intraepithelial neoplasia (DIN) classification.
    Tavassoli FA
    Nat Clin Pract Oncol; 2005 Mar; 2(3):116-7. PubMed ID: 16264885
    [No Abstract]   [Full Text] [Related]  

  • 54. Lobular carcinoma in situ or atypical lobular hyperplasia at core-needle biopsy: is excisional biopsy necessary?
    Foster MC; Helvie MA; Gregory NE; Rebner M; Nees AV; Paramagul C
    Radiology; 2004 Jun; 231(3):813-9. PubMed ID: 15105449
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Minimal breast cancer: advance or anachronism?
    Wolmark N
    Can J Surg; 1985 May; 28(3):252-5. PubMed ID: 2986808
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Use of immunohistochemistry in the diagnosis of problematic breast lesions.
    Lee AH
    J Clin Pathol; 2013 Jun; 66(6):471-7. PubMed ID: 23486609
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Long-term follow-up of in situ carcinoma of the breast with special emphasis on clinging carcinoma.
    Eusebi V; Foschini MP; Cook MG; Berrino F; Azzopardi JG
    Semin Diagn Pathol; 1989 May; 6(2):165-73. PubMed ID: 2548274
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pathobiology of breast cancer--treatment implications.
    Vorherr H
    Eur J Obstet Gynecol Reprod Biol; 1984 May; 17(2-3):219-35. PubMed ID: 6329835
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Genetic abnormalities in mammary ductal intraepithelial neoplasia-flat type ("clinging ductal carcinoma in situ"): a simulator of normal mammary epithelium.
    Moinfar F; Man YG; Bratthauer GL; Ratschek M; Tavassoli FA
    Cancer; 2000 May; 88(9):2072-81. PubMed ID: 10813719
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The prevalence of carcinoma in situ in normal and cancer-associated breasts.
    Alpers CE; Wellings SR
    Hum Pathol; 1985 Aug; 16(8):796-807. PubMed ID: 2991111
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.